Assessment of Risk in Thoracic Aortopathy Using 18F-Sodium Fluoride

CompletedOBSERVATIONAL
Enrollment

95

Participants

Timeline

Start Date

April 1, 2019

Primary Completion Date

September 3, 2023

Study Completion Date

September 3, 2023

Conditions
Bicuspid Aortic ValveThoracic Aortic AneurysmAortic Dissection
Interventions
DIAGNOSTIC_TEST

clinical evaluation, blood markers, pulse wave analysis, 18F sodium fluoride PET/CT and PET/MRI

Patients will receive a structured clinic history, examination, blood sampling, pulse wave analysis, pulse wave velocity, 18F-sodium fluoride PET/CT, 18F-sodium fluoride PET/MRI with detailed cardiac magnetic resonance imaging and magnetic resonance imaging of the aorta

DIAGNOSTIC_TEST

Repeat 18F sodium fluoride PET/MRI

as per first study visit but without the PET/CT

Trial Locations (1)

EH16 4SB

University of Edinburgh, Edinburgh

All Listed Sponsors
lead

University of Edinburgh

OTHER

NCT04083118 - Assessment of Risk in Thoracic Aortopathy Using 18F-Sodium Fluoride | Biotech Hunter | Biotech Hunter